What is AbbVie's treasury stock, shares (in shares)?

AbbVie (ABBV) reported treasury stock, shares (in shares) of 77.1M in Q1 2026.

How has AbbVie's treasury stock, shares (in shares) changed year-over-year?

AbbVie's treasury stock, shares (in shares) increased by 8.9% year-over-year, from 70.8M to 77.1M.

What is the long-term trend for AbbVie's treasury stock, shares (in shares)?

Over 3 years (2022 to 2025), AbbVie's treasury stock, shares (in shares) has grown at a 16.7% compound annual growth rate (CAGR), from 44.6M to 70.8M.

AbbVie ABBV Treasury stock, shares (in shares)

Treasury stock, shares (in shares) at other companies

Cardinal HealthCAH

——

Establishment LabsESTA

——

Other financials

Income statement

See full

Revenue$15.0B+12.4%

Gross profit$10.8B+15.4%

Operating income$4.0B+6.9%

Net income$695.0M-46.0%

EPS (diluted)$0.39-45.8%

Balance sheet

See full

Cash & equivalents$9.4B+81.5%

Total debt$62.4B+1.8%

Total equity-$6.7B-569%

Total assets$136.46B+0.2%

Cash flow

See full

Operating cash flow$3.8B+134%

CapEx$265.0M+12.8%

Free cash flow$3.6B+155%

Valuation

See full

Market cap$444.6B+39.8%

P/E122.3×+37.8×

P/S7.1×+1.6×

Profitability

See full

Gross margin70.7%0.0pp

Operating margin24.4%—

Net margin5.8%-1.5pp

FCF margin31.8%+5.0pp

Returns & leverage

See full

Return on equity89%+32.7pp

Debt / equity46.6×+38.6×

Current ratio0.8×0.0×

Where this comes from

Reported directly by AbbVie in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.

The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbbVie's treasury stock, shares (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AbbVie's treasury stock, shares (in shares)?: AbbVie (ABBV) reported treasury stock, shares (in shares) of 77.1M in Q1 2026.
How has AbbVie's treasury stock, shares (in shares) changed year-over-year?: AbbVie's treasury stock, shares (in shares) increased by 8.9% year-over-year, from 70.8M to 77.1M.
What is the long-term trend for AbbVie's treasury stock, shares (in shares)?: Over 3 years (2022 to 2025), AbbVie's treasury stock, shares (in shares) has grown at a 16.7% compound annual growth rate (CAGR), from 44.6M to 70.8M.